HIGHLIGHTS
- who: Qianqian Xin from the Fudan University of Public Health Safety, Ministry of Education, Shanghai, China have published the research: Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials, in the Journal: NATURE COMMUNICATIONS NATURE COMMUNICATIONS of June/12,/2020
- what: Multicentre studies will be needed to assess primary outcomes among subpopulations for whom the study had relatively small proportions, for example, people with multiple underlying conditions or immunosuppressive conditions.
- how: The authors conducted a study to assess immune persistence after a homologous booster . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.